These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 23881657)

  • 41. Risperidone versus olanzapine for schizophrenia.
    Jayaram MB; Hosalli P; Stroup S
    Cochrane Database Syst Rev; 2006 Apr; (2):CD005237. PubMed ID: 16625629
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aripiprazole versus other atypical antipsychotics for schizophrenia.
    Khanna P; Komossa K; Rummel-Kluge C; Hunger H; Schwarz S; El-Sayeh HG; Leucht S
    Cochrane Database Syst Rev; 2013 Feb; (2):CD006569. PubMed ID: 23450570
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risperidone versus olanzapine for schizophrenia.
    Jayaram MB; Hosalli P
    Cochrane Database Syst Rev; 2005 Apr; (2):CD005237. PubMed ID: 15846745
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aripiprazole versus typicals for schizophrenia.
    Bhattacharjee J; El-Sayeh HG
    Cochrane Database Syst Rev; 2008 Jan; (1):CD006617. PubMed ID: 18254107
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Haloperidol versus placebo for schizophrenia.
    Joy CB; Adams CE; Lawrie SM
    Cochrane Database Syst Rev; 2006 Oct; (4):CD003082. PubMed ID: 17054159
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cessation of medication for people with schizophrenia already stable on chlorpromazine.
    Almerie MQ; Alkhateeb H; Essali A; Matar HE; Rezk E
    Cochrane Database Syst Rev; 2007 Jan; (1):CD006329. PubMed ID: 17253586
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Calcium channel blockers for antipsychotic-induced tardive dyskinesia.
    Essali A; Soares-Weiser K; Bergman H; Adams CE
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD000206. PubMed ID: 29578611
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre-post studies.
    Kishimoto T; Hagi K; Kurokawa S; Kane JM; Correll CU
    Lancet Psychiatry; 2021 May; 8(5):387-404. PubMed ID: 33862018
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fluphenazine (oral) versus placebo for schizophrenia.
    Matar HE; Almerie MQ; Sampson S
    Cochrane Database Syst Rev; 2013 Jul; 7(7):CD006352. PubMed ID: 23861067
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Olanzapine for schizophrenia.
    Duggan L; Fenton M; Rathbone J; Dardennes R; El-Dosoky A; Indran S
    Cochrane Database Syst Rev; 2005 Apr; (2):CD001359. PubMed ID: 15846619
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nidotherapy for people with schizophrenia.
    Chamberlain IJ; Sampson S
    Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD009929. PubMed ID: 23543583
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Music therapy for people with schizophrenia and schizophrenia-like disorders.
    Geretsegger M; Mössler KA; Bieleninik Ł; Chen XJ; Heldal TO; Gold C
    Cochrane Database Syst Rev; 2017 May; 5(5):CD004025. PubMed ID: 28553702
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Electroconvulsive therapy for schizophrenia.
    Tharyan P; Adams CE
    Cochrane Database Syst Rev; 2005 Apr; (2):CD000076. PubMed ID: 15846598
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia.
    Tardy M; Dold M; Engel RR; Leucht S
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD009396. PubMed ID: 25003310
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Benzodiazepines alone or in combination with antipsychotic drugs for acute psychosis.
    Gillies D; Beck A; McCloud A; Rathbone J; Gillies D
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003079. PubMed ID: 16235313
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aripiprazole versus placebo for schizophrenia.
    Belgamwar RB; El-Sayeh HG
    Cochrane Database Syst Rev; 2011 Aug; (8):CD006622. PubMed ID: 21833956
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Benzodiazepines for neuroleptic-induced tardive dyskinesia.
    Umbrich P; Soares KV
    Cochrane Database Syst Rev; 2003; (2):CD000205. PubMed ID: 12804389
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia.
    Bighelli I; Rodolico A; Siafis S; Samara MT; Hansen WP; Salomone S; Aguglia E; Cutrufelli P; Bauer I; Baeckers L; Leucht S
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD014383. PubMed ID: 36042158
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Miscellaneous treatments for neuroleptic-induced tardive dyskinesia.
    Soares-Weiser KV; Joy C
    Cochrane Database Syst Rev; 2003; (2):CD000208. PubMed ID: 12804390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.